These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38001391)

  • 21. Annexin A2 in renal cell carcinoma: expression, function, and prognostic significance.
    Yang SF; Hsu HL; Chao TK; Hsiao CJ; Lin YF; Cheng CW
    Urol Oncol; 2015 Jan; 33(1):22.e11-22.e21. PubMed ID: 25284003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis.
    Nørgaard M; Haldrup C; Storebjerg TM; Vestergaard EM; Wild PJ; Høyer S; Borre M; Ørntoft TF; Sørensen KD
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28930171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma.
    Wang Y; Chen K; Cai Y; Cai Y; Yuan X; Wang L; Wu Z; Wu Y
    J Exp Clin Cancer Res; 2017 Aug; 36(1):111. PubMed ID: 28814318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and prognostic role of annexin A2 in multiple myeloma.
    Seckinger A; Meissner T; Moreaux J; Depeweg D; Hillengass J; Hose K; Rème T; Rösen-Wolff A; Jauch A; Schnettler R; Ewerbeck V; Goldschmidt H; Klein B; Hose D
    Blood; 2012 Aug; 120(5):1087-94. PubMed ID: 22705595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of Annexin A2 expression in oral squamous cell carcinoma and its influence on cell proliferation, migration and invasion.
    Ma Y; Wang H
    Sci Rep; 2021 Mar; 11(1):5033. PubMed ID: 33658625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Annexin A2: its molecular regulation and cellular expression in cancer development.
    Wang CY; Lin CF
    Dis Markers; 2014; 2014():308976. PubMed ID: 24591759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
    Wang Y; Deng J; Guo G; Tong A; Peng X; Chen H; Xu J; Liu Y; You C; Zhou L
    J Neurooncol; 2017 Jan; 131(1):21-29. PubMed ID: 27640198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
    Han Q; Li J; Xiong J; Song Z
    J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomics identification of annexin A2 as a key mediator in the metastasis and proangiogenesis of endometrial cells in human adenomyosis.
    Zhou S; Yi T; Liu R; Bian C; Qi X; He X; Wang K; Li J; Zhao X; Huang C; Wei Y
    Mol Cell Proteomics; 2012 Jul; 11(7):M112.017988. PubMed ID: 22493182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylation-mediated LINC00261 suppresses pancreatic cancer progression by epigenetically inhibiting c-Myc transcription.
    Liu S; Zheng Y; Zhang Y; Zhang J; Xie F; Guo S; Gu J; Yang J; Zheng P; Lai J; Yin L; Wang H
    Theranostics; 2020; 10(23):10634-10651. PubMed ID: 32929371
    [No Abstract]   [Full Text] [Related]  

  • 31. Biological Effect and Mechanism of the miR-23b-3p/ANXA2 Axis in Pancreatic Ductal Adenocarcinoma.
    Wei DM; Dang YW; Feng ZB; Liang L; Zhang L; Tang RX; Chen ZM; Yu Q; Wei YC; Luo DZ; Chen G
    Cell Physiol Biochem; 2018; 50(3):823-840. PubMed ID: 30355917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma.
    Deng L; Gao Y; Li X; Cai M; Wang H; Zhuang H; Tan M; Liu S; Hao Y; Lin B
    J Exp Clin Cancer Res; 2015 Sep; 34(1):96. PubMed ID: 26362938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating annexin A2 as a biomarker in patients with pancreatic cancer.
    Karabulut M; Afsar CU; Serilmez M; Karabulut S
    J Cancer Res Ther; 2020 Dec; 16(Supplement):S110-S115. PubMed ID: 33380663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer.
    Griner NB; Young D; Chaudhary P; Mohamed AA; Huang W; Chen Y; Sreenath T; Dobi A; Petrovics G; Vishwanatha JK; Sesterhenn IA; Srivastava S; Tan SH
    Mol Cancer Res; 2015 Feb; 13(2):368-79. PubMed ID: 25344575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
    Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
    J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signal transducer and activator of transcription 6 (STAT6) is a novel interactor of annexin A2 in prostate cancer cells.
    Das S; Shetty P; Valapala M; Dasgupta S; Gryczynski Z; Vishwanatha JK
    Biochemistry; 2010 Mar; 49(10):2216-26. PubMed ID: 20121258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppression.
    Ma K; Chen X; Liu W; Yang Y; Chen S; Sun J; Ma C; Wang T; Yang J
    Sci Rep; 2021 Oct; 11(1):20839. PubMed ID: 34675316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of pancreatic juice proteins as biomarkers of pancreatic cancer.
    Gao J; Zhu F; Lv S; Li Z; Ling Z; Gong Y; Jie C; Ma L
    Oncol Rep; 2010 Jun; 23(6):1683-92. PubMed ID: 20428826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies.
    Kim VM; Blair AB; Lauer P; Foley K; Che X; Soares K; Xia T; Muth ST; Kleponis J; Armstrong TD; Wolfgang CL; Jaffee EM; Brockstedt D; Zheng L
    J Immunother Cancer; 2019 May; 7(1):132. PubMed ID: 31113479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coexpression of ANXA2, SOD2 and HOXA13 predicts poor prognosis of esophageal squamous cell carcinoma.
    Ma RL; Shen LY; Chen KN
    Oncol Rep; 2014 May; 31(5):2157-64. PubMed ID: 24626613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.